<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-07-11" modified="2020-10-07" version="195">
<accession>Q15022</accession>
<accession>Q96BD9</accession>
<name>SUZ12_HUMAN</name>
<protein>
<recommendedName>
<fullName>Polycomb protein SUZ12</fullName>
</recommendedName>
<alternativeName>
<fullName>Chromatin precipitated E2F target 9 protein</fullName>
<shortName>ChET 9 protein</shortName>
</alternativeName>
<alternativeName>
<fullName>Joined to JAZF1 protein</fullName>
</alternativeName>
<alternativeName>
<fullName>Suppressor of zeste 12 protein homolog</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">SUZ12</name>
<name type="synonym">CHET9</name>
<name type="synonym">JJAZ1</name>
<name type="synonym">KIAA0160</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1995" name="DNA Res." volume="2" first="167" last="174">
<title>Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1.</title>
<authorList>
<person name="Nagase T."/>
<person name="Seki N."/>
<person name="Tanaka A."/>
<person name="Ishikawa K."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="8590280"/>
<dbReference type="DOI" id="10.1093/dnares/2.4.167"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<scope>VARIANT ILE-216</scope>
<source>
<tissue>Bone marrow</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Uterus</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2001" name="Proc. Natl. Acad. Sci. U.S.A." volume="98" first="6348" last="6353">
<title>Frequent fusion of the JAZF1 and JJAZ1 genes in endometrial stromal tumors.</title>
<authorList>
<person name="Koontz J.I."/>
<person name="Soreng A.L."/>
<person name="Nucci M."/>
<person name="Kuo F.C."/>
<person name="Pauwels P."/>
<person name="van Den Berghe H."/>
<person name="Cin P.D."/>
<person name="Fletcher J.A."/>
<person name="Sklar J."/>
</authorList>
<dbReference type="PubMed" id="11371647"/>
<dbReference type="DOI" id="10.1073/pnas.101132598"/>
</citation>
<scope>DISEASE</scope>
<scope>CHROMOSOMAL TRANSLOCATION WITH JAZF1</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2001" name="Mol. Cell. Biol." volume="21" first="6820" last="6832">
<title>Use of chromatin immunoprecipitation to clone novel E2F target promoters.</title>
<authorList>
<person name="Weinmann A.S."/>
<person name="Bartley S.M."/>
<person name="Zhang T."/>
<person name="Zhang M.Q."/>
<person name="Farnham P.J."/>
</authorList>
<dbReference type="PubMed" id="11564866"/>
<dbReference type="DOI" id="10.1128/mcb.21.20.6820-6832.2001"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2002" name="Genes Dev." volume="16" first="2893" last="2905">
<title>Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein.</title>
<authorList>
<person name="Kuzmichev A."/>
<person name="Nishioka K."/>
<person name="Erdjument-Bromage H."/>
<person name="Tempst P."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="12435631"/>
<dbReference type="DOI" id="10.1101/gad.1035902"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE PRC2 COMPLEX WITH EED; EZH2; RBBP4 AND RBBP7</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2002" name="Science" volume="298" first="1039" last="1043">
<title>Role of histone H3 lysine 27 methylation in Polycomb-group silencing.</title>
<authorList>
<person name="Cao R."/>
<person name="Wang L."/>
<person name="Wang H."/>
<person name="Xia L."/>
<person name="Erdjument-Bromage H."/>
<person name="Tempst P."/>
<person name="Jones R.S."/>
<person name="Zhang Y."/>
</authorList>
<dbReference type="PubMed" id="12351676"/>
<dbReference type="DOI" id="10.1126/science.1076997"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE PRC2 COMPLEX WITH EED; EZH2; RBBP4 AND RBBP7</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="EMBO J." volume="22" first="5323" last="5335">
<title>EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.</title>
<authorList>
<person name="Bracken A.P."/>
<person name="Pasini D."/>
<person name="Capra M."/>
<person name="Prosperini E."/>
<person name="Colli E."/>
<person name="Helin K."/>
</authorList>
<dbReference type="PubMed" id="14532106"/>
<dbReference type="DOI" id="10.1093/emboj/cdg542"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="EMBO J." volume="23" first="4061" last="4071">
<title>Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity.</title>
<authorList>
<person name="Pasini D."/>
<person name="Bracken A.P."/>
<person name="Jensen M.R."/>
<person name="Lazzerini Denchi E."/>
<person name="Helin K."/>
</authorList>
<dbReference type="PubMed" id="15385962"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600402"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EZH2</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
<scope>DEVELOPMENTAL STAGE</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genes Dev." volume="18" first="1592" last="1605">
<title>Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27.</title>
<authorList>
<person name="Kirmizis A."/>
<person name="Bartley S.M."/>
<person name="Kuzmichev A."/>
<person name="Margueron R."/>
<person name="Reinberg D."/>
<person name="Green R."/>
<person name="Farnham P.J."/>
</authorList>
<dbReference type="PubMed" id="15231737"/>
<dbReference type="DOI" id="10.1101/gad.1200204"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2004" name="Mol. Cell" volume="14" first="183" last="193">
<title>Different EZH2-containing complexes target methylation of histone H1 or nucleosomal histone H3.</title>
<authorList>
<person name="Kuzmichev A."/>
<person name="Jenuwein T."/>
<person name="Tempst P."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="15099518"/>
<dbReference type="DOI" id="10.1016/s1097-2765(04)00185-6"/>
</citation>
<scope>CHARACTERIZATION OF THE PRC2 AND PRC3 COMPLEXES INCLUDING EED; EZH2; RBBP4; RBBP7 AND SUZ12</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 AND PRC3 COMPLEXES</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Mol. Cell" volume="15" first="57" last="67">
<title>SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex.</title>
<authorList>
<person name="Cao R."/>
<person name="Zhang Y."/>
</authorList>
<dbReference type="PubMed" id="15225548"/>
<dbReference type="DOI" id="10.1016/j.molcel.2004.06.020"/>
</citation>
<scope>FUNCTION</scope>
<scope>CHARACTERIZATION OF THE PRC2 COMPLEX INCLUDING AEBP2; EED; EZH2; RBBP4 AND SUZ12</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2005" name="Proc. Natl. Acad. Sci. U.S.A." volume="102" first="1859" last="1864">
<title>Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.</title>
<authorList>
<person name="Kuzmichev A."/>
<person name="Margueron R."/>
<person name="Vaquero A."/>
<person name="Preissner T.S."/>
<person name="Scher M."/>
<person name="Kirmizis A."/>
<person name="Ouyang X."/>
<person name="Brockdorff N."/>
<person name="Abate-Shen C."/>
<person name="Farnham P.J."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="15684044"/>
<dbReference type="DOI" id="10.1073/pnas.0409875102"/>
</citation>
<scope>CHARACTERIZATION OF THE PRC4 COMPLEX INCLUDING EED; EZH2; RBBP4; RBBP7; SUZ12 AND SIRT1</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC4 COMPLEX</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2005" name="Science" volume="310" first="306" last="310">
<title>Akt-mediated phosphorylation of EZH2 suppresses methylation of lysine 27 in histone H3.</title>
<authorList>
<person name="Cha T.-L."/>
<person name="Zhou B.P."/>
<person name="Xia W."/>
<person name="Wu Y."/>
<person name="Yang C.-C."/>
<person name="Chen C.-T."/>
<person name="Ping B."/>
<person name="Otte A.P."/>
<person name="Hung M.-C."/>
</authorList>
<dbReference type="PubMed" id="16224021"/>
<dbReference type="DOI" id="10.1126/science.1118947"/>
</citation>
<scope>INTERACTION WITH EZH2</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Biochem. Biophys. Res. Commun." volume="345" first="1051" last="1058">
<title>Association of Polycomb group SUZ12 with WD-repeat protein MEP50 that binds to histone H2A selectively in vitro.</title>
<authorList>
<person name="Furuno K."/>
<person name="Masatsugu T."/>
<person name="Sonoda M."/>
<person name="Sasazuki T."/>
<person name="Yamamoto K."/>
</authorList>
<dbReference type="PubMed" id="16712789"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2006.05.014"/>
</citation>
<scope>INTERACTION WITH WDR77</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2006" name="Genes Dev." volume="20" first="1123" last="1136">
<title>Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.</title>
<authorList>
<person name="Bracken A.P."/>
<person name="Dietrich N."/>
<person name="Pasini D."/>
<person name="Hansen K.H."/>
<person name="Helin K."/>
</authorList>
<dbReference type="PubMed" id="16618801"/>
<dbReference type="DOI" id="10.1101/gad.381706"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="J. Biol. Chem." volume="281" first="8365" last="8370">
<title>Substrate preferences of the EZH2 histone methyltransferase complex.</title>
<authorList>
<person name="Martin C."/>
<person name="Cao R."/>
<person name="Zhang Y."/>
</authorList>
<dbReference type="PubMed" id="16431907"/>
<dbReference type="DOI" id="10.1074/jbc.m513425200"/>
</citation>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
<scope>INTERACTION WITH HISTONE H1</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2007" name="Genes Dev." volume="21" first="525" last="530">
<title>The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells.</title>
<authorList>
<person name="Bracken A.P."/>
<person name="Kleine-Kohlbrecher D."/>
<person name="Dietrich N."/>
<person name="Pasini D."/>
<person name="Gargiulo G."/>
<person name="Beekman C."/>
<person name="Theilgaard-Moench K."/>
<person name="Minucci S."/>
<person name="Porse B.T."/>
<person name="Marine J.-C."/>
<person name="Hansen K.H."/>
<person name="Helin K."/>
</authorList>
<dbReference type="PubMed" id="17344414"/>
<dbReference type="DOI" id="10.1101/gad.415507"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Nat. Genet." volume="39" first="232" last="236">
<title>Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer.</title>
<authorList>
<person name="Schlesinger Y."/>
<person name="Straussman R."/>
<person name="Keshet I."/>
<person name="Farkash S."/>
<person name="Hecht M."/>
<person name="Zimmerman J."/>
<person name="Eden E."/>
<person name="Yakhini Z."/>
<person name="Ben-Shushan E."/>
<person name="Reubinoff B.E."/>
<person name="Bergman Y."/>
<person name="Simon I."/>
<person name="Cedar H."/>
</authorList>
<dbReference type="PubMed" id="17200670"/>
<dbReference type="DOI" id="10.1038/ng1950"/>
</citation>
<scope>DE NOVO DNA METHYLATION OF PRC2 TARGET GENES</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546 AND SER-583</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2008" name="Mol. Cell" volume="32" first="503" last="518">
<title>Ezh1 and Ezh2 maintain repressive chromatin through different mechanisms.</title>
<authorList>
<person name="Margueron R."/>
<person name="Li G."/>
<person name="Sarma K."/>
<person name="Blais A."/>
<person name="Zavadil J."/>
<person name="Woodcock C.L."/>
<person name="Dynlacht B.D."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="19026781"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.11.004"/>
</citation>
<scope>IDENTIFICATION IN THE PRC2/EED-EZH1 COMPLEX</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="1862" last="1872">
<title>Role of hPHF1 in H3K27 methylation and Hox gene silencing.</title>
<authorList>
<person name="Cao R."/>
<person name="Wang H."/>
<person name="He J."/>
<person name="Erdjument-Bromage H."/>
<person name="Tempst P."/>
<person name="Zhang Y."/>
</authorList>
<dbReference type="PubMed" id="18086877"/>
<dbReference type="DOI" id="10.1128/mcb.01589-07"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>IDENTIFICATION IN THE PRC2 COMPLEX</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="2718" last="2731">
<title>Ezh2 requires PHF1 to efficiently catalyze H3 lysine 27 trimethylation in vivo.</title>
<authorList>
<person name="Sarma K."/>
<person name="Margueron R."/>
<person name="Ivanov A."/>
<person name="Pirrotta V."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="18285464"/>
<dbReference type="DOI" id="10.1128/mcb.02017-07"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH EED AND EZH2</scope>
<scope>INTERACTION OF THE PRC2 COMPLEX WITH PHF1</scope>
<scope>METHYLTRANSFERASE ACTIVITY OF THE PRC2 COMPLEX</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="PLoS ONE" volume="3" first="E2704" last="E2704">
<title>The polycomb repressive complex 2 is a potential target of SUMO modifications.</title>
<authorList>
<person name="Riising E.M."/>
<person name="Boggio R."/>
<person name="Chiocca S."/>
<person name="Helin K."/>
<person name="Pasini D."/>
</authorList>
<dbReference type="PubMed" id="18628979"/>
<dbReference type="DOI" id="10.1371/journal.pone.0002704"/>
</citation>
<scope>SUMOYLATION AT LYS-72; LYS-73 AND LYS-75</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Science" volume="321" first="1357" last="1361">
<title>A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells.</title>
<authorList>
<person name="Li H."/>
<person name="Wang J."/>
<person name="Mor G."/>
<person name="Sklar J."/>
</authorList>
<dbReference type="PubMed" id="18772439"/>
<dbReference type="DOI" id="10.1126/science.1156725"/>
</citation>
<scope>TRANS-SPLICING</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="42414" last="42425">
<title>Corepressor protein CDYL functions as a molecular bridge between polycomb repressor complex 2 and repressive chromatin mark trimethylated histone lysine 27.</title>
<authorList>
<person name="Zhang Y."/>
<person name="Yang X."/>
<person name="Gui B."/>
<person name="Xie G."/>
<person name="Zhang D."/>
<person name="Shang Y."/>
<person name="Liang J."/>
</authorList>
<dbReference type="PubMed" id="22009739"/>
<dbReference type="DOI" id="10.1074/jbc.m111.271064"/>
</citation>
<scope>INTERACTION WITH CDYL</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-546</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-20; SER-541; SER-546 AND SER-726</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="33">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.o113.027870"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="34">
<citation type="journal article" date="2017" name="Hum. Mutat." volume="38" first="637" last="648">
<title>Mutations in genes encoding polycomb repressive complex 2 subunits cause Weaver syndrome.</title>
<authorList>
<person name="Imagawa E."/>
<person name="Higashimoto K."/>
<person name="Sakai Y."/>
<person name="Numakura C."/>
<person name="Okamoto N."/>
<person name="Matsunaga S."/>
<person name="Ryo A."/>
<person name="Sato Y."/>
<person name="Sanefuji M."/>
<person name="Ihara K."/>
<person name="Takada Y."/>
<person name="Nishimura G."/>
<person name="Saitsu H."/>
<person name="Mizuguchi T."/>
<person name="Miyatake S."/>
<person name="Nakashima M."/>
<person name="Miyake N."/>
<person name="Soejima H."/>
<person name="Matsumoto N."/>
</authorList>
<dbReference type="PubMed" id="28229514"/>
<dbReference type="DOI" id="10.1002/humu.23200"/>
</citation>
<scope>INVOLVEMENT IN IMMAS</scope>
<scope>VARIANT IMMAS VAL-610</scope>
<scope>CHARACTERIZATION OF VARIANT IMMAS VAL-610</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-75; LYS-223 AND LYS-390</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2019" name="Neuro-oncol." volume="21" first="878" last="889">
<title>EZHIP / CXorf67 mimics K27M mutated oncohistones and functions as an intrinsic inhibitor of PRC2 function in aggressive posterior fossa ependymoma.</title>
<authorList>
<person name="Huebner J.M."/>
<person name="Mueller T."/>
<person name="Papageorgiou D.N."/>
<person name="Mauermann M."/>
<person name="Krijgsveld J."/>
<person name="Russell R.B."/>
<person name="Ellison D.W."/>
<person name="Pfister S.M."/>
<person name="Pajtler K.W."/>
<person name="Kool M."/>
</authorList>
<dbReference type="PubMed" id="30923826"/>
<dbReference type="DOI" id="10.1093/neuonc/noz058"/>
</citation>
<scope>INTERACTION WITH EZHIP</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2018" name="Clin. Genet." volume="94" first="461" last="466">
<title>Novel SUZ12 mutations in Weaver-like syndrome.</title>
<authorList>
<person name="Imagawa E."/>
<person name="Albuquerque E.V.A."/>
<person name="Isidor B."/>
<person name="Mitsuhashi S."/>
<person name="Mizuguchi T."/>
<person name="Miyatake S."/>
<person name="Takata A."/>
<person name="Miyake N."/>
<person name="Boguszewski M.C.S."/>
<person name="Boguszewski C.L."/>
<person name="Lerario A.M."/>
<person name="Funari M.A."/>
<person name="Jorge A.A.L."/>
<person name="Matsumoto N."/>
</authorList>
<dbReference type="PubMed" id="30019515"/>
<dbReference type="DOI" id="10.1111/cge.13415"/>
</citation>
<scope>VARIANT IMMAS HIS-599</scope>
<scope>INVOLVEMENT IN IMMAS</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2019" name="Am. J. Med. Genet. C. Semin. Med. Genet." volume="181" first="532" last="547">
<title>Rare SUZ12 variants commonly cause an overgrowth phenotype.</title>
<authorList>
<consortium name="C.A.U.S.E.S. Study"/>
<person name="Cyrus S.S."/>
<person name="Cohen A.S.A."/>
<person name="Agbahovbe R."/>
<person name="Avela K."/>
<person name="Yeung K.S."/>
<person name="Chung B.H.Y."/>
<person name="Luk H.M."/>
<person name="Tkachenko N."/>
<person name="Choufani S."/>
<person name="Weksberg R."/>
<person name="Lopez-Rangel E."/>
<person name="Brown K."/>
<person name="Saenz M.S."/>
<person name="Svihovec S."/>
<person name="McCandless S.E."/>
<person name="Bird L.M."/>
<person name="Garcia A.G."/>
<person name="Gambello M.J."/>
<person name="McWalter K."/>
<person name="Schnur R.E."/>
<person name="An J."/>
<person name="Jones S.J.M."/>
<person name="Bhalla S.K."/>
<person name="Pinz H."/>
<person name="Braddock S.R."/>
<person name="Gibson W.T."/>
</authorList>
<dbReference type="PubMed" id="31736240"/>
<dbReference type="DOI" id="10.1002/ajmg.c.31748"/>
</citation>
<scope>VARIANTS IMMAS GLN-535; LEU-603 AND 654-ARG--LEU-739 DEL</scope>
</reference>
<comment type="function">
<text evidence="19 20 21 25 27 29 33">Polycomb group (PcG) protein. Component of the PRC2/EED-EZH2 complex, which methylates 'Lys-9' (H3K9me) and 'Lys-27' (H3K27me) of histone H3, leading to transcriptional repression of the affected target gene. The PRC2/EED-EZH2 complex may also serve as a recruiting platform for DNA methyltransferases, thereby linking two epigenetic repression systems. Genes repressed by the PRC2/EED-EZH2 complex include HOXC8, HOXA9, MYT1 and CDKN2A.</text>
</comment>
<comment type="subunit">
<text evidence="16 17 21 23 24 26 28 29 31 32 35">Component of the PRC2/EED-EZH2 complex, which includes EED, EZH2, SUZ12, RBBP4 and RBBP7 and possibly AEBP2. The minimum components required for methyltransferase activity of the PRC2/EED-EZH2 complex are EED, EZH2 and SUZ12. Component of the PRC2/EED-EZH1 complex, which includes EED, EZH1, SUZ12, RBBP4 and AEBP2. The PRC2 complex may also interact with DNMT1, DNMT3A, DNMT3B and PHF1 via the EZH2 subunit and with SIRT1 via the SUZ12 subunit. Interacts with WDR77. Interacts with histone H1. Interacts with CDYL. Interacts with ARNTL/BMAL1. Interacts with EZHIP (via C-terminal region) (PubMed:30923826).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1264675">
<id>Q15022</id>
</interactant>
<interactant intactId="EBI-923794">
<id>O75530</id>
<label>EED</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1264675">
<id>Q15022</id>
</interactant>
<interactant intactId="EBI-530054">
<id>Q15910</id>
<label>EZH2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>22</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1264675">
<id>Q15022</id>
</interactant>
<interactant intactId="EBI-607682">
<id>O15379</id>
<label>HDAC3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1264675">
<id>Q15022</id>
</interactant>
<interactant intactId="EBI-6678255">
<id>Q14774</id>
<label>HLX</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1264675">
<id>Q15022</id>
</interactant>
<interactant intactId="EBI-15825247">
<id>Q92833-1</id>
<label>JARID2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1264675">
<id>Q15022</id>
</interactant>
<interactant intactId="EBI-867256">
<id>Q15156</id>
<label>PML-RAR</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="20">Nucleus</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="20 22">Overexpressed in breast and colon cancer.</text>
</comment>
<comment type="developmental stage">
<text evidence="21">Expressed at low levels in quiescent cells. Expression rises at the G1/S phase transition.</text>
</comment>
<comment type="induction">
<text evidence="15 18">Expression is induced by E2F1, E2F2 and E2F3.</text>
</comment>
<comment type="PTM">
<text evidence="30">Sumoylated, probably by PIAS2.</text>
</comment>
<comment type="disease">
<text evidence="14">A chromosomal aberration involving SUZ12 may be a cause of endometrial stromal tumors. Translocation t(7;17)(p15;q21) with JAZF1. The translocation generates the JAZF1-SUZ12 oncogene consisting of the N-terminus part of JAZF1 and the C-terminus part of SUZ12. It is frequently found in all cases of endometrial stromal tumors, except in endometrial stromal sarcomas, where it is rarer.</text>
</comment>
<comment type="disease" evidence="33 34 36">
<disease id="DI-05768">
<name>Imagawa-Matsumoto syndrome</name>
<acronym>IMMAS</acronym>
<description>An autosomal dominant syndrome characterized by generalized overgrowth, dysmorphic features, musculoskeletal abnormalities, developmental delay and intellectual disability. Some patients have genitourinary and structural brain abnormalities.</description>
<dbReference type="MIM" id="618786"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text evidence="40">Under hypoxic conditions, the precursor SUZ12 RNA undergoes regulated trans-splicing with the JAZF1 RNA, resulting in a chimeric isoform which may be protective against apoptosis. The chimeric transcript is characterized by JAZF1 exons 1-3 joined to SUZ12 exon 2-16. The chimeric transcript is expressed primarily in the endometrium from late secretory and early proliferative phases of the menstrual cycle, but not in normal myometrium at any phase of the cycle. Its expression is slightly induced by low levels of progesterone, but suppressed by both estrogen and high levels of progesterone (PubMed:18772439).</text>
</comment>
<comment type="similarity">
<text evidence="38">Belongs to the VEFS (VRN2-EMF2-FIS2-SU(Z)12) family.</text>
</comment>
<comment type="caution">
<text evidence="39">Two variants of the PRC2 complex have been described, termed PRC3 and PRC4. Each of the three complexes may include a different complement of EED isoforms, although the precise sequences of the isoforms in each complex have not been determined. The PRC2 and PRC4 complexes may also methylate 'Lys-26' of histone H1 in addition to 'Lys-27' of histone H3 (PubMed:15099518 and PubMed:15684044), although other studies have demonstrated no methylation of 'Lys-26' of histone H1 by PRC2 (PubMed:16431907).</text>
</comment>
<comment type="sequence caution" evidence="38">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAA09931" version="2"/>
</conflict>
<text>Extended N-terminus.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/JJAZ1ID41039ch17q11.html"/>
</comment>
<dbReference type="EMBL" id="D63881">
<property type="protein sequence ID" value="BAA09931.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC015704">
<property type="protein sequence ID" value="AAH15704.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS11270.1"/>
<dbReference type="RefSeq" id="NP_056170.2">
<property type="nucleotide sequence ID" value="NM_015355.3"/>
</dbReference>
<dbReference type="PDB" id="4W2R">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.81"/>
<property type="chains" value="S/T=545-725"/>
</dbReference>
<dbReference type="PDB" id="5HYN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.95"/>
<property type="chains" value="C/H/M/S=558-685"/>
</dbReference>
<dbReference type="PDB" id="5IJ7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.62"/>
<property type="chains" value="S/T=545-725"/>
</dbReference>
<dbReference type="PDB" id="5IJ8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.99"/>
<property type="chains" value="S/T=545-725"/>
</dbReference>
<dbReference type="PDB" id="5LS6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.47"/>
<property type="chains" value="C/F/I/L=558-685"/>
</dbReference>
<dbReference type="PDB" id="5WAI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="B/F=76-545"/>
</dbReference>
<dbReference type="PDB" id="5WAK">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="B=76-545"/>
</dbReference>
<dbReference type="PDB" id="5WG6">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="A/C=543-695"/>
</dbReference>
<dbReference type="PDB" id="6B3W">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.05"/>
<property type="chains" value="S/T=545-725"/>
</dbReference>
<dbReference type="PDB" id="6C23">
<property type="method" value="EM"/>
<property type="resolution" value="3.90"/>
<property type="chains" value="A/M/Q=1-739"/>
</dbReference>
<dbReference type="PDB" id="6C24">
<property type="method" value="EM"/>
<property type="resolution" value="3.50"/>
<property type="chains" value="A/M/Q=1-739"/>
</dbReference>
<dbReference type="PDB" id="6NQ3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.89"/>
<property type="chains" value="B/F=76-545"/>
</dbReference>
<dbReference type="PDBsum" id="4W2R"/>
<dbReference type="PDBsum" id="5HYN"/>
<dbReference type="PDBsum" id="5IJ7"/>
<dbReference type="PDBsum" id="5IJ8"/>
<dbReference type="PDBsum" id="5LS6"/>
<dbReference type="PDBsum" id="5WAI"/>
<dbReference type="PDBsum" id="5WAK"/>
<dbReference type="PDBsum" id="5WG6"/>
<dbReference type="PDBsum" id="6B3W"/>
<dbReference type="PDBsum" id="6C23"/>
<dbReference type="PDBsum" id="6C24"/>
<dbReference type="PDBsum" id="6NQ3"/>
<dbReference type="SMR" id="Q15022"/>
<dbReference type="BioGRID" id="117059">
<property type="interactions" value="550"/>
</dbReference>
<dbReference type="CORUM" id="Q15022"/>
<dbReference type="DIP" id="DIP-38524N"/>
<dbReference type="IntAct" id="Q15022">
<property type="interactions" value="51"/>
</dbReference>
<dbReference type="MINT" id="Q15022"/>
<dbReference type="STRING" id="9606.ENSP00000316578"/>
<dbReference type="BindingDB" id="Q15022"/>
<dbReference type="ChEMBL" id="CHEMBL3137286"/>
<dbReference type="ChEMBL" id="CHEMBL3137287"/>
<dbReference type="ChEMBL" id="CHEMBL3301388"/>
<dbReference type="iPTMnet" id="Q15022"/>
<dbReference type="PhosphoSitePlus" id="Q15022"/>
<dbReference type="BioMuta" id="SUZ12"/>
<dbReference type="DMDM" id="116242808"/>
<dbReference type="EPD" id="Q15022"/>
<dbReference type="jPOST" id="Q15022"/>
<dbReference type="MassIVE" id="Q15022"/>
<dbReference type="MaxQB" id="Q15022"/>
<dbReference type="PaxDb" id="Q15022"/>
<dbReference type="PeptideAtlas" id="Q15022"/>
<dbReference type="PRIDE" id="Q15022"/>
<dbReference type="ProteomicsDB" id="60374"/>
<dbReference type="Antibodypedia" id="27067">
<property type="antibodies" value="347 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000322652">
<property type="protein sequence ID" value="ENSP00000316578"/>
<property type="gene ID" value="ENSG00000178691"/>
</dbReference>
<dbReference type="GeneID" id="23512"/>
<dbReference type="KEGG" id="hsa:23512"/>
<dbReference type="UCSC" id="uc002hgs.3">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="23512"/>
<dbReference type="DisGeNET" id="23512"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000178691.10"/>
<dbReference type="GeneCards" id="SUZ12"/>
<dbReference type="HGNC" id="HGNC:17101">
<property type="gene designation" value="SUZ12"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000178691">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MalaCards" id="SUZ12"/>
<dbReference type="MIM" id="606245">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="618786">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q15022"/>
<dbReference type="OpenTargets" id="ENSG00000178691"/>
<dbReference type="Orphanet" id="213711">
<property type="disease" value="Endometrial stromal sarcoma"/>
</dbReference>
<dbReference type="Orphanet" id="3447">
<property type="disease" value="Weaver syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA134936035"/>
<dbReference type="eggNOG" id="KOG2350">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000012364"/>
<dbReference type="InParanoid" id="Q15022"/>
<dbReference type="KO" id="K11463"/>
<dbReference type="OMA" id="RNEKMFG"/>
<dbReference type="OrthoDB" id="516359at2759"/>
<dbReference type="PhylomeDB" id="Q15022"/>
<dbReference type="TreeFam" id="TF323249"/>
<dbReference type="PathwayCommons" id="Q15022"/>
<dbReference type="Reactome" id="R-HSA-212300">
<property type="pathway name" value="PRC2 methylates histones and DNA"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2559580">
<property type="pathway name" value="Oxidative Stress Induced Senescence"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-3214841">
<property type="pathway name" value="PKMTs methylate histone lysines"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4551638">
<property type="pathway name" value="SUMOylation of chromatin organization proteins"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5617472">
<property type="pathway name" value="Activation of anterior HOX genes in hindbrain development during early embryogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8943724">
<property type="pathway name" value="Regulation of PTEN gene transcription"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8953750">
<property type="pathway name" value="Transcriptional Regulation by E2F6"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-9609690">
<property type="pathway name" value="HCMV Early Events"/>
</dbReference>
<dbReference type="SignaLink" id="Q15022"/>
<dbReference type="SIGNOR" id="Q15022"/>
<dbReference type="BioGRID-ORCS" id="23512">
<property type="hits" value="136 hits in 880 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SUZ12">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="SUZ12"/>
<dbReference type="GenomeRNAi" id="23512"/>
<dbReference type="Pharos" id="Q15022">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q15022"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 17"/>
</dbReference>
<dbReference type="RNAct" id="Q15022">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000178691">
<property type="expression patterns" value="Expressed in female gonad and 247 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q15022">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q15022">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0035098">
<property type="term" value="C:ESC/E(Z) complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016604">
<property type="term" value="C:nuclear body"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032993">
<property type="term" value="C:protein-DNA complex"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001739">
<property type="term" value="C:sex chromatin"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0031490">
<property type="term" value="F:chromatin DNA binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042054">
<property type="term" value="F:histone methyltransferase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0046872">
<property type="term" value="F:metal ion binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0035064">
<property type="term" value="F:methylated histone binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1990841">
<property type="term" value="F:promoter-specific chromatin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0000978">
<property type="term" value="F:RNA polymerase II cis-regulatory region sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001226">
<property type="term" value="F:RNA polymerase II transcription corepressor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070734">
<property type="term" value="P:histone H3-K27 methylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0016574">
<property type="term" value="P:histone ubiquitination"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045596">
<property type="term" value="P:negative regulation of cell differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070317">
<property type="term" value="P:negative regulation of G0 to G1 transition"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045814">
<property type="term" value="P:negative regulation of gene expression, epigenetic"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008284">
<property type="term" value="P:positive regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR019135">
<property type="entry name" value="Polycomb_protein_VEFS-Box"/>
</dbReference>
<dbReference type="Pfam" id="PF09733">
<property type="entry name" value="VEFS-Box"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00028">
<property type="entry name" value="ZINC_FINGER_C2H2_1"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0160">Chromosomal rearrangement</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0656">Proto-oncogene</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="Polycomb protein SUZ12" id="PRO_0000047057">
<location>
<begin position="1"/>
<end position="739"/>
</location>
</feature>
<feature type="zinc finger region" description="C2H2-type">
<location>
<begin position="448"/>
<end position="471"/>
</location>
</feature>
<feature type="region of interest" description="VEFS-box">
<location>
<begin position="563"/>
<end position="639"/>
</location>
</feature>
<feature type="compositionally biased region" description="Gly-rich">
<location>
<begin position="7"/>
<end position="50"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="51"/>
<end position="59"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ala">
<location>
<begin position="60"/>
<end position="67"/>
</location>
</feature>
<feature type="site" description="Breakpoint for translocation to form JAZF1-SUZ12 oncogene">
<location>
<begin position="93"/>
<end position="94"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="20"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="541"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6 7 8 9 10 11 12">
<location>
<position position="546"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="7">
<location>
<position position="583"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="726"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="30">
<location>
<position position="72"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)" evidence="30">
<location>
<position position="73"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate" evidence="30">
<location>
<position position="75"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="13">
<location>
<position position="75"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="13">
<location>
<position position="223"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="13">
<location>
<position position="390"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17339444." id="VAR_028100" evidence="37">
<original>N</original>
<variation>I</variation>
<location>
<position position="216"/>
</location>
</feature>
<feature type="sequence variant" description="In IMMAS; unknown pathological significance." id="VAR_083817" evidence="36">
<original>R</original>
<variation>Q</variation>
<location>
<position position="535"/>
</location>
</feature>
<feature type="sequence variant" description="In IMMAS." id="VAR_083818" evidence="34">
<original>Q</original>
<variation>H</variation>
<location>
<position position="599"/>
</location>
</feature>
<feature type="sequence variant" description="In IMMAS." id="VAR_083819" evidence="36">
<original>F</original>
<variation>L</variation>
<location>
<position position="603"/>
</location>
</feature>
<feature type="sequence variant" description="In IMMAS; decreased trimethylation of 'Lys-27' of histone H3; no effect on interaction with EZH2; dbSNP:rs1131692177." id="VAR_078318" evidence="33">
<original>E</original>
<variation>V</variation>
<location>
<position position="610"/>
</location>
</feature>
<feature type="sequence variant" description="In IMMAS." id="VAR_083820" evidence="36">
<location>
<begin position="654"/>
<end position="739"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="80"/>
<end position="82"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="83"/>
<end position="106"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="112"/>
<end position="114"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="116"/>
<end position="121"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="128"/>
<end position="131"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="136"/>
<end position="142"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="157"/>
<end position="160"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="185"/>
<end position="193"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="198"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="203"/>
<end position="207"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="229"/>
<end position="232"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="234"/>
<end position="236"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="241"/>
<end position="243"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="245"/>
<end position="253"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="296"/>
<end position="302"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="312"/>
<end position="316"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="354"/>
<end position="358"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="370"/>
<end position="372"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="376"/>
<end position="378"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="427"/>
<end position="434"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="437"/>
<end position="441"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="446"/>
<end position="449"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="451"/>
<end position="453"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="460"/>
<end position="470"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="471"/>
<end position="473"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="474"/>
<end position="481"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="484"/>
<end position="491"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="506"/>
<end position="508"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="516"/>
<end position="518"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="525"/>
<end position="531"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="541"/>
<end position="543"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="544"/>
<end position="547"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="568"/>
<end position="570"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="576"/>
<end position="578"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="590"/>
<end position="601"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="604"/>
<end position="606"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="608"/>
<end position="624"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="629"/>
<end position="631"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="632"/>
<end position="649"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="653"/>
<end position="665"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="671"/>
<end position="686"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5IJ7"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5WAI"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5WAK"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6C24"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6NQ3"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11371647"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11564866"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12351676"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12435631"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14532106"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15225548"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15231737"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15385962"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15684044"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16224021"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16431907"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16618801"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16712789"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344414"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18086877"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18285464"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18628979"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19026781"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22009739"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28229514"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30019515"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30923826"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="31736240"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8590280"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000305"/>
<evidence key="39" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="16431907"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="18772439"/>
</source>
</evidence>
<sequence length="739" mass="83055" checksum="A8830EBC3FD38D56" modified="2006-10-17" version="3">MAPQKHGGGGGGGSGPSAGSGGGGFGGSAAVAAATASGGKSGGGSCGGGGSYSASSSSSAAAAAGAAVLPVKKPKMEHVQADHELFLQAFEKPTQIYRFLRTRNLIAPIFLHRTLTYMSHRNSRTNIKRKTFKVDDMLSKVEKMKGEQESHSLSAHLQLTFTGFFHKNDKPSPNSENEQNSVTLEVLLVKVCHKKRKDVSCPIRQVPTGKKQVPLNPDLNQTKPGNFPSLAVSSNEFEPSNSHMVKSYSLLFRVTRPGRREFNGMINGETNENIDVNEELPARRKRNREDGEKTFVAQMTVFDKNRRLQLLDGEYEVAMQEMEECPISKKRATWETILDGKRLPPFETFSQGPTLQFTLRWTGETNDKSTAPIAKPLATRNSESLHQENKPGSVKPTQTIAVKESLTTDLQTRKEKDTPNENRQKLRIFYQFLYNNNTRQQTEARDDLHCPWCTLNCRKLYSLLKHLKLCHSRFIFNYVYHPKGARIDVSINECYDGSYAGNPQDIHRQPGFAFSRNGPVKRTPITHILVCRPKRTKASMSEFLESEDGEVEQQRTYSSGHNRLYFHSDTCLPLRPQEMEVDSEDEKDPEWLREKTITQIEEFSDVNEGEKEVMKLWNLHVMKHGFIADNQMNHACMLFVENYGQKIIKKNLCRNFMLHLVSMHDFNLISIMSIDKAVTKLREMQQKLEKGESASPANEEITEEQNGTANGFSEINSKEKALETDSVSGVSKQSKKQKL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

